-
00:19
1.
大腸直腸癌的藥物治療
-
01:41
1.1
各癌別標準化發生率
-
03:07
2.
抗癌藥物治療
-
02:46
2.1
結腸癌的治療
-
01:02
2.2
直腸癌的治療
-
06:19
3.
傳統化療 ↔ 標靶治療？
-
00:17
4.
細胞毒性化學治療
-
00:55
5.
5-FU (Fluorouracil)
-
01:33
5.1
5-FU (Fluorouracil)
-
02:04
5.2
5-FU (Fluorouracil)
-
00:44
6.
口服5-FU製劑
-
00:34
6.1
UFUR® (友復)
-
00:32
6.2
Capecitabine (Xeloda®, 截瘤達)
-
01:09
6.3
Capecitabine (Xeloda®, 截瘤達)
-
01:33
7.
Irinotecan (Campto®,抗癌妥)
-
01:10
7.1
Irinotecan (Campto®,抗癌妥)
-
01:06
8.
Oxaliplatin (Oxalip®,歐力普)
-
03:06
8.1
Oxaliplatin (Oxalip®,歐力普)
-
00:12
9.
標靶治療
-
03:02
9.1
標靶藥物作用方式
-
03:16
10.
Cetuximab (Erbitux®, 爾必得舒)
-
00:33
10.1
Cetuximab (Erbitux®, 爾必得舒)
-
00:52
11.
Panitumumab (Vectibix®,維必施)
-
01:15
12.
Bevacizumab (Avastin®, 癌思停)
-
00:37
12.1
Bevacizumab (Avastin®, 癌思停)
-
00:10
12.2
Bevacizumab (Avastin®, 癌思停)
-
00:25
13.
Aflibercept (Zaltrap®,柔癌捕)
-
00:24
13.1
Bevacizumab (Avastin®, 癌思停)
-
00:04
13.2
Aflibercept (Zaltrap®,柔癌捕)
-
01:04
14.
Ramucirumab (Cyramza®,欣銳擇)
-
00:17
14.1
Aflibercept (Zaltrap®,柔癌捕)
-
00:39
14.2
Bevacizumab (Avastin®, 癌思停)
-
00:01
14.3
Ramucirumab (Cyramza®,欣銳擇)
-
00:11
14.4
Ramucirumab (Cyramza®,欣銳擇)
-
01:51
15.
健保下早期大腸癌治療通則
-
00:33
16.
健保下晚期大腸直腸癌第一線治療
-
01:54
16.1
健保下晚期大腸直腸癌第一線治療
-
00:28
16.2
健保下晚期大腸直腸癌第一線治療
-
01:04
16.3
健保下晚期大腸直腸癌第二線治療
-
03:10
17.
Regorafenib (Stivarga®,癌瑞格)
-
01:56
18.
Regorafenib (Stivarga®,癌瑞格)
-
00:19
1.
大腸直腸癌的藥物治療
-
01:41
1.1
各癌別標準化發生率
-
03:07
2.
抗癌藥物治療
-
02:46
2.1
結腸癌的治療
-
01:02
2.2
直腸癌的治療
-
06:19
3.
傳統化療 ↔ 標靶治療？
-
00:17
4.
細胞毒性化學治療
-
00:55
5.
5-FU (Fluorouracil)
-
01:33
5.1
5-FU (Fluorouracil)
-
02:04
5.2
5-FU (Fluorouracil)
-
00:44
6.
口服5-FU製劑
-
00:34
6.1
UFUR® (友復)
-
00:32
6.2
Capecitabine (Xeloda®, 截瘤達)
-
01:09
6.3
Capecitabine (Xeloda®, 截瘤達)
-
01:33
7.
Irinotecan (Campto®,抗癌妥)
-
01:10
7.1
Irinotecan (Campto®,抗癌妥)
-
01:06
8.
Oxaliplatin (Oxalip®,歐力普)
-
03:06
8.1
Oxaliplatin (Oxalip®,歐力普)
-
00:12
9.
標靶治療
-
03:02
9.1
標靶藥物作用方式
-
03:16
10.
Cetuximab (Erbitux®, 爾必得舒)
-
00:33
10.1
Cetuximab (Erbitux®, 爾必得舒)
-
00:52
11.
Panitumumab (Vectibix®,維必施)
-
01:15
12.
Bevacizumab (Avastin®, 癌思停)
-
00:37
12.1
Bevacizumab (Avastin®, 癌思停)
-
00:10
12.2
Bevacizumab (Avastin®, 癌思停)
-
00:25
13.
Aflibercept (Zaltrap®,柔癌捕)
-
00:24
13.1
Bevacizumab (Avastin®, 癌思停)
-
00:04
13.2
Aflibercept (Zaltrap®,柔癌捕)
-
01:04
14.
Ramucirumab (Cyramza®,欣銳擇)
-
00:17
14.1
Aflibercept (Zaltrap®,柔癌捕)
-
00:39
14.2
Bevacizumab (Avastin®, 癌思停)
-
00:01
14.3
Ramucirumab (Cyramza®,欣銳擇)
-
00:11
14.4
Ramucirumab (Cyramza®,欣銳擇)
-
01:51
15.
健保下早期大腸癌治療通則
-
00:33
16.
健保下晚期大腸直腸癌第一線治療
-
01:54
16.1
健保下晚期大腸直腸癌第一線治療
-
00:28
16.2
健保下晚期大腸直腸癌第一線治療
-
01:04
16.3
健保下晚期大腸直腸癌第二線治療
-
03:10
17.
Regorafenib (Stivarga®,癌瑞格)
-
01:56
18.
Regorafenib (Stivarga®,癌瑞格)